ELKE PLATZ MD, MS , KIRSTY MCDOWELL MBChB , DEEPAK K. GUPTA MD, MSCI , BRIAN CLAGGETT PhD , ALICE BRENNAN MBChB , LAWRENCE J. CHARLES MD , JONATHAN W. CUNNINGHAM MD, MPH , DEBRA D. DIXON MD, MS , KIERAN F. DOCHERTY MBChB, PhD , KAROLA JERING MD , RASHUNDRA OGGS NP , JULIA PALACIOS BS , MADELEINE SCHWEDE BA , KATHERINE SCOVNER RAVI MD, MPH , SHIVASANKAR M. SUKUMAR MBChB , JEAN W. WASSENAAR MD, PhD , ELDRIN F. LEWIS MD, MPH , JOHN J.V. MCMURRAY MBChB, MD , ROSS T. CAMPBELL MBChB, PhD
{"title":"Pulmonary Congestion on Lung Ultrasound in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction","authors":"ELKE PLATZ MD, MS , KIRSTY MCDOWELL MBChB , DEEPAK K. GUPTA MD, MSCI , BRIAN CLAGGETT PhD , ALICE BRENNAN MBChB , LAWRENCE J. CHARLES MD , JONATHAN W. CUNNINGHAM MD, MPH , DEBRA D. DIXON MD, MS , KIERAN F. DOCHERTY MBChB, PhD , KAROLA JERING MD , RASHUNDRA OGGS NP , JULIA PALACIOS BS , MADELEINE SCHWEDE BA , KATHERINE SCOVNER RAVI MD, MPH , SHIVASANKAR M. SUKUMAR MBChB , JEAN W. WASSENAAR MD, PhD , ELDRIN F. LEWIS MD, MPH , JOHN J.V. MCMURRAY MBChB, MD , ROSS T. CAMPBELL MBChB, PhD","doi":"10.1016/j.cardfail.2025.02.013","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Early detection of pulmonary congestion among ambulatory patients with heart failure with preserved ejection fraction (HFpEF) is critical to optimize decongestive therapy before overt decompensation, yet traditional tools are insensitive. We sought to examine the prevalence of B-lines, an ultrasound measure of pulmonary congestion, and their clinical and imaging correlates in patients with HFpEF.</div></div><div><h3>Methods and Results</h3><div>In a prospective, multisite observational study, using a pocket ultrasound device, 8-zone lung ultrasound examination was performed in outpatients with HFpEF, left ventricular ejection fraction (LVEF) of ≥45% and New York Heart Association functional class II through IV. B-lines and cardiac structure and function from echocardiograms were quantified off-line in core laboratories, blinded to clinical findings. Among 415 participants (mean age 74 years, 52% women, 51% obese, median N-terminal pro-B-type natriuretic peptide [NT-proBNP] 744 pg/mL) B-lines were detectable in 78% of patients ranging from 0 to 36 (median 3, interquartile range 1–6). There was a linear association between B-line count and log-transformed NT-proBNP (<em>P</em> < .001). Among patients in the highest tertile of B-lines, 76% had no crackles on auscultation, and 50% did not have elevated NT-proBNP levels. A higher B-line count was associated with larger sizes of cardiac chambers, greater left ventricular mass, higher filling pressures (E/e'), tricuspid regurgitant velocity, and inferior vena cava size, and worse right ventricular systolic function (<em>P</em> for trend < .05 for all), but not left ventricular ejection fraction.</div></div><div><h3>Conclusions</h3><div>Among ambulatory patients with HFpEF, lung ultrasound-detected B-lines were common, associated with NT-proBNP levels and clinically important echocardiographic features, and identified pulmonary congestion that was not always evident by auscultation.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"32 3","pages":"Pages 557-568"},"PeriodicalIF":8.2000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiac Failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1071916425000995","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Early detection of pulmonary congestion among ambulatory patients with heart failure with preserved ejection fraction (HFpEF) is critical to optimize decongestive therapy before overt decompensation, yet traditional tools are insensitive. We sought to examine the prevalence of B-lines, an ultrasound measure of pulmonary congestion, and their clinical and imaging correlates in patients with HFpEF.
Methods and Results
In a prospective, multisite observational study, using a pocket ultrasound device, 8-zone lung ultrasound examination was performed in outpatients with HFpEF, left ventricular ejection fraction (LVEF) of ≥45% and New York Heart Association functional class II through IV. B-lines and cardiac structure and function from echocardiograms were quantified off-line in core laboratories, blinded to clinical findings. Among 415 participants (mean age 74 years, 52% women, 51% obese, median N-terminal pro-B-type natriuretic peptide [NT-proBNP] 744 pg/mL) B-lines were detectable in 78% of patients ranging from 0 to 36 (median 3, interquartile range 1–6). There was a linear association between B-line count and log-transformed NT-proBNP (P < .001). Among patients in the highest tertile of B-lines, 76% had no crackles on auscultation, and 50% did not have elevated NT-proBNP levels. A higher B-line count was associated with larger sizes of cardiac chambers, greater left ventricular mass, higher filling pressures (E/e'), tricuspid regurgitant velocity, and inferior vena cava size, and worse right ventricular systolic function (P for trend < .05 for all), but not left ventricular ejection fraction.
Conclusions
Among ambulatory patients with HFpEF, lung ultrasound-detected B-lines were common, associated with NT-proBNP levels and clinically important echocardiographic features, and identified pulmonary congestion that was not always evident by auscultation.
期刊介绍:
Journal of Cardiac Failure publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure - pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment.